Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34081848

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2021 Jun 24
First author
Tutt ANJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2021 Oct;18(10):607-608. doi: 10.1038/s41571-021-00544-7.
    note
    Source null
    related pmid
    34282304
    relationship
    Comment in
  2. citation
    N Engl J Med. 2021 Oct 7;385(15):1439. doi: 10.1056/NEJMc2112373.
    note
    Source null
    related pmid
    34614336
    relationship
    Comment in
  3. citation
    N Engl J Med. 2021 Oct 7;385(15):1439-1440. doi: 10.1056/NEJMc2112373.
    note
    Source null
    related pmid
    34614337
    relationship
    Comment in

Authors and identifiers

  1. name
    Tutt ANJ
    type
    Author
  2. name
    Garber JE
    type
    Author
  3. name
    Kaufman B
    type
    Author
  4. name
    Viale G
    type
    Author
  5. name
    Fumagalli D
    type
    Author
  6. name
    Rastogi P
    type
    Author
  7. name
    Gelber RD
    type
    Author
  8. name
    de Azambuja E
    type
    Author
  9. name
    Fielding A
    type
    Author
  10. name
    Balmaña J
    type
    Author
  11. name
    Domchek SM
    type
    Author
  12. name
    Gelmon KA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Tutt ANJ
    type
    Author
  2. name
    Garber JE
    type
    Author
  3. name
    Kaufman B
    type
    Author
  4. name
    Viale G
    type
    Author
  5. name
    Fumagalli D
    type
    Author
  6. name
    Rastogi P
    type
    Author
  7. name
    Gelber RD
    type
    Author
  8. name
    de Azambuja E
    type
    Author
  9. name
    Fielding A
    type
    Author
  10. name
    Balmaña J
    type
    Author
  11. name
    Domchek SM
    type
    Author
  12. name
    Gelmon KA
    type
    Author
bibliography ids
  1. nci-bib-8ca6a0c9ad9e1fda370fdf1a
book metadata
content sha256
a155c3e265cbca5f4fab172d8525ac4229f35afd766170eaa76ff98fc5566f1e
document type
citation
dois
  1. 10.1056/NEJMoa2105215
electronic publication date
display
2021 Jun 3
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34081848
immutable id
pubmed:34081848@a155c3e265cbca5f4fab172d8525ac4229f35afd766170eaa76ff98fc5566f1e
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
25
name
The New England journal of medicine
nlm unique id
0255562
pages
2394-2405
volume
384
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2021 Oct;18(10):607-608. doi: 10.1038/s41571-021-00544-7.
    note
    Source null
    related pmid
    34282304
    relationship
    Comment in
  2. citation
    N Engl J Med. 2021 Oct 7;385(15):1439. doi: 10.1056/NEJMc2112373.
    note
    Source null
    related pmid
    34614336
    relationship
    Comment in
  3. citation
    N Engl J Med. 2021 Oct 7;385(15):1439-1440. doi: 10.1056/NEJMc2112373.
    note
    Source null
    related pmid
    34614337
    relationship
    Comment in
outcomes validated
false
pmid
34081848
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
e34fb826601f16ffa732c25da8ee8a0381913b0bbeb6be932d8353b8cc307317
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Jun 24
precision
day
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34081848/
title
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.

Preserved source evidence · Not medical advice